Table 1 Comparison between infliximab and non-infliximab

Age (years)

60 (47–66)

66 (42–91)

Sex (m/w)

6/1

11/7

BMI (kg/m²)

32.4 (24.0–36.1)

28.7 (22–45)

ICU admission (n)

6 (86%)

15 (88%)

Death related to COVID-19

1 (14.2%)

6 (35.3%)

Mechanical ventilation (n)

3 (42.8%)

9 (52.9%)

ECMO (n)

2 (28.6%)

1 (5.9%)

RR syst (mmHg)

110 (100–125)

128 (94–174)

AF (1/min)

24 (18–39)

27 (16–42)

HF (1/min)

72 (61–120)

84 (60–127)

SpO₂ (%)

91 (89–96)

92 (84–99)

Temperature (°C)

37.7 (36.2–37.7)

37.1 (36.7–39.4)

WBC (Gpt/l)

8.9 (3.4–16.4)

7.0 (2.2–13)

CRP (mg/l)

178.1 (113.4–401.3)

187 (18.7–323)

PCT (ng/ml)

0.28 (0.06–15.99)

0.58 (0.1–11)

Ferritin (μg/l)

2777.4 (697–70,693.8)

1453.0 (124.7–7391)

d-dimer (μg/l)

683 (10.2–48,588)

475.5 (146–8015)

LDH

10.6 (8.23–131.65)

6.54 (3.31–11.8)

Creatinine (mmol/l)

92.0 (59–303)

77.5 (55–384)^a

ALAT (μmol/l*s)

2.79 (0.62–3.19)

0.55 (0.1–2.93)